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Abstract
Aim
Emergence and spread of multidrug-resistant (MDR) 
microorganisms in healthcare settings, especially in 
Intensive Care Units (ICUs), cause concern worldwide. A 
particular problem is a lack of therapeutic options. One 
of the inducement factors for MDR microorganisms 
spread is antibiotic over- and wrong-prescribing. 
Surgical antibiotic prophylaxis is one of the misused 
antibiotic prescribing indications. The aims of our study 
were to determine the prevalence of five key MDR 
bacteria from blood and urine in order to establish 
surgical antibiotic prophylaxis compliance with the 
Croatian National Guidelines.
Methods
A point prevalence study was conducted. We present a 
laboratory-based WHO designed survey on MRSA, VRE, 
ESBL and CRE-producing Enterobacteriaceae, multi-
resistant Acinetobacter spp., isolated from blood and 
urine of hospitalised patients. Surgical prophylaxis data 
were gathered from patients who had undergone 
operative procedures in the General Surgery Ward and 
Gynecology Ward.
Results
The prevalence of MRSA bloodstream infections was 
1.64%, other MDR microorganisms were not isolated. 
The prevalence of urine MDR isolates was MRSA 0.07%, 
E. coli ESBL 1.43% (5.79% of overall E. coli isolates were 
ESBL producers), K. pneumonie 1.79% (26.3% of K. 
pneumoniae were ESBL producers) and Acinetobacter 
spp. 0.38%. The proportion of patients who continued 
surgical prophylaxis was 6.4%. 
Conclusion
MDR microorganisms’ prevalence in our institution is 
low, but the proportion of resistant strains within 
isolated species corresponds to European reports. 
Surgical antibiotic prophylaxis compliance with the 
Croatian National Guidelines is high. 
Constant and recent surveillance data are a significant 
guide for empiric antimicrobial therapy, an indicator 
for activities concerning the prevention of MDR 
microorganisms spread and proper antibiotic 
stewardship.
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Pojava i širenje višestruko otpornih mikroorganizama 
(MDR) u okruženju zdravstvene njege, posebice u 
jedinicama za intenzivno liječenje, uzrokuju zabrinutost 
diljem svijeta. Poseban problem je nedostatak 
terapeutskih mogućnosti. Jedan od uzročnih faktora 
širenja MDR mikroorganizama je pretjerano ili pogrešno 
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propisivanje antibiotika. Ciljevi ove studije bili su 
utvrditi prevalenciju pet najvažnijih MDR bakterija iz 
krvi i urina da bi se kirurška antibiotička profilaksa 
uskladila s Hrvatskim nacionalnim smjernicama.
Metode
Provedena je studija prevalencije infekcija u određenom 
vremenu. Prikazani su laboratorijski podaci o sljedećim 
bakterijskim uzročnicima infekcija: MRSA, VRE, ESBL i 
enterobakterije koje produciraju karbapenemaze, te 
višestruko otporna Acinetobacter spp., izolirane iz krvi i 
urina hospitaliziranih pacijenata. Podaci o kirurškoj 
profilaksi prikupljeni su od pacijenata koji su bili 
podvrgnuti operativnim zahvatima na Odjelu opće 
kirurgije i Odjelu ginekologije.
Rezultati
Prevalencija MRSA infekcija krvi bila je 1,64%, drugi 
MDR mikroorganizmi nisu bili izolirani. Prevalencija 
urinarnih MDR izolata bila je sljedeća: MRSA 0,07%, E. 
coli ESBL 1,43% (5,79% ukupnih E. coli izolata bilo je 
onih koji proizvode ESBL), K. pneumonie 1,79% (26,3% 
K. pneumoniae bilo je proizvođač ESBL-a) i Acinetobacter 
spp. 0,38%. Udio pacijenata koji su nastavili s kirurškom 
profilaksom bio je 6,4%.
Zaključak
Prevalencija MDR mikroorganizama u našoj instituciji je 
niska, no udio otpornih izolata među izoliranim vrstama 
odgovara europskim izvješćima. Usklađenost kirurške 
antibiotičke profilakse sa Smjernicama je visoka.
Kontinuirani i aktualni podaci važna su uputa za 
provođenje empirijske antimikrobne terapije, pokaza-
telj za načine sprečavanja širenja MDR mikroorganiza-
ma i ispravno korištenje antibiotika.
Ključne riječi
otpornost na lijekove, višestruki, bakterijski, Gram-
pozitivne bakterije, Gram-negativne bakterije, 
prevalencija, antibiotska profilaksa
Introduction
Global emergence and spread of multidrug-resistant 
(MDR) microorganisms in healthcare settings, especially 
in Intensive Care Units, cause concern worldwide. 
Healthcare-associated infections in already critically ill 
patients are associated with prolonged length of 
hospitalisation and increased morbidity and mortality 
[1, 2]. National or multicentre point prevalence surveys 
of healthcare-associated infections performed in 
developed countries have shown that the percentage 
of patients with a nosocomial infection on any given 
day in acute care hospitals is on average 7.1%, ranging 
from 3.5% to 10.5%, with main infections of urinary 
tract (27%), lower respiratory tract infections including 
pneumonia (24%), surgical site infections (17%) and 
bloodstream infections (10.5%) [3]. The most frequent 
cause of these infections are Gram-negative bacteria 
Escherichia coli, Klebsiella pneumonie, other 
Enterobacteriaceae species, Acinetobacter spp. and 
Gram-positive bacteria Staphylococcus aureus and 
Enterococcus spp. All these pathogens have the ability 
of developing effective resistance mechanisms to 
antimicrobial agents used and becoming multidrug-
resistant (MDR) strains presenting a significant problem 
in therapy optimization because the initial empirical 
antibiotic choice can be inadequate and there will be a 
lack of antimicrobial therapeutic options in the future, 
since no new class of antimicrobials has been 
developed recently [4]. Surveillance of MDR 
microorganisms is a fundamental part of an effective 
response to this threat and surveillance results 
constitute the essential source of information on 
magnitude and trends in resistance [5]. It has been 
identified that one of the inducement factors for 
selection of bacterial strains with diverse resistance 
mechanisms and their consequent spread is hospital 
environment with antibiotic selective pressure [6]. An 
additional problem is over- and wrong- prescribing of 
antibiotics within healthcare facilities, despite guidance 
being available. Surgical antibiotic prophylaxis is one of 
the misused antibiotic prescribing indications. 
World Health Organisation (WHO) recognized the 
potentially devastating consequences of these issues 
and has put the spread of antibimicrobial resistance 
into focus of 2014 WHO – SAVE LIVES: Clean Your Hands 
global campaign. Since 2009, on May 5th (Hand 
Hygiene Day), the campaign has launched a call to 
action to implement and sustain hand hygiene 
improvement worldwide, to reduce transmission of 
MDR pathogens causing healthcare-associated 
infections. WHO proposed a global survey on MDR 
microorganisms burden and surgical antibiotic 
prophylaxis use, to raise awareness and promote 
activities in restraining the beginning of postantibiotic 
era, such as hand hygiene and antibiotic stewardship 
[7]. Since our institution is taking part in WHO – SAVE 
LIVES: Clean Your Hands campaign, the aims of our 
study were to determine the prevalence of five key 
Gram-positive and Gram-negative multidrug-resistant 
microorganisms from blood and urinary specimens 
and to establish the prevalence of compliance with 
surgical antibiotic prophylaxis guidelines determining 
the proportion of patients who continue surgical 
antibiotic prophylaxis after operative procedures in 
absence of any infections, either surgical or non-
surgical, in order to describe the types of antibiotic 
prophylaxis prescribed and to ascertain the reasons for 
prophylaxis prolongation. 
Materials and methods
A point prevalence study on multidrug-resistant 
bacteria and surgical antibiotic prophylaxis was 
conducted. A laboratory-based study, using WHO 
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designed survey, was conducted during one week 
(from March 21st to 28th, 2014) at the University 
Hospital Centre Sestre Milosrdnice Department of 
Microbiology, Parasitology and Hospital Infection. 
Gram-positive multidrug-resistant bacteria (methicillin-
resistant Staphylococcus aureus – MRSA and 
vancomycin-resistant enterococci – VRE) and Gram-
negative multidrug-resistant bacteria (extended-
spectrum β-lactamase ESBL producing Enterobacte-
riaceae – ESBL, carbapenem-resistant Enterobacte-
riaceae – CRE and multi-resistant Acinetobacter spp. 
– MRAB) isolated from blood culture (aerobic and 
anaerobic blood culture sets) and urine (mid-stream or 
catheter specimen) of hospitalised patients routinely 
submitted to our microbiology laboratory, excluding 
copy strains, were registered in electronic form. 
Susceptibility patterns of phenotipically identified 
microorganisms were determined using disk diffusion 
method. Minimum inhibitory concentration (MIC) of 
vancomycin was determined by E-test (bioMerieux, 
France). European Committee on Antimicrobial 
Susceptibility Testing (EUCAST) antibiotic susceptibility 
interpretative criteria were used [8]. ESBL is a beta-
lactamase that mediates resistance to all cephalosporins 
and monobactams (aztreonam), but does not effect 
carbapenems and cephamycin. CRE Enterobacteriaceae 
produce any beta-lactamase that hydrolises 
carbapenems (any or all of ertapenem, doripenem, 
imipenem and meropenem). MRAB Acinetobacter spp. 
isolate is resistant to at least three classes of 
antimicrobials (penicillins, cephalosporins, flouroquino-
lones and aminoglycosides). 
Surgical prophylaxis data were gathered using WHO 
designed survey with a “closed-question” questionnaire 
by a hospital infection control professional in one day 
(March 27th, 2014), from patients hospitalised in the 
General Surgery Ward and Gynecology Ward at the 
University Hospital Centre Sestre Milosrdnice Clinic for 
Tumors. Data were collected from patient records (and 
by asking clinical ward staff if necessary) on all patients 
who had operative procedure in the previous three 
consecutive working days excluding the day of the 
survey (March 24th, 25th and 26th, 2014). Surgical 
antibiotic prophylaxis was defined as administration of 
systemic antibiotics before surgical procedure 
optimally within 60 minutes (exceptions are 
vancomycin and flouroquinolones), with possible 
repetition during the operation depending on its 
duration. Surgical procedures were classified according 
to the National Healthcare Safety Networklist of 
Operative Procedures Categories (CDC). Surgical 
wounds were classified using Wound Classification. 
Type 1 are clean, non-traumatic, uninfected operative 
wounds in which no inflammation is encountered. 
There is no break in (sterile) technique and the 
respiratory, alimentary, or genitourinary tracts or the 
oropharyngeal cavities are not entered. Clean wounds 
are primarily closed and, if necessary, drained with 
closed drainage. Type 2 is an operative wound that 
enters the respiratory, GI, genital or urinary tract under 
controlled conditions without unusual contamination 
when no infection or major break in technique has 
occurred. Type 3 are contaminated wounds which 
occur when the operation is associated with open, 
fresh and accidental wounds. In addition, this is a 
surgical procedure in which a major break in sterile 
technique occurs or gross spillage from the 
gastrointestinal tract and incisions in which acute, non-
purulent inflammation is encountered. Type 4 are dirty 
or infected wounds involving old traumatic wounds 
with retained or devitalised tissue and those that 
involve an existing clinical infection or perforated 
viscera. This definition suggests that the organisms 
causing postoperative infection were present in the 
operative field before the surgical procedure [9]. Each 
operative procedure was compared with the 
Interdisciplinary Section for Antibiotic Resistance 
Control (ISKRA) of the Croatian National Guidelines for 
Antimicrobial Prophylaxis in Surgery [10].
Results
During the study period 61 blood culture sets were 
processed. In 6.56% blood cultures of different 
microorganisms were isolated. The prevalence of MRSA 
bloodstream infections was 1.64%, while other MDR 
microorganisms were not isolated. Other isolated 
microorganisms were E. coli and K. pneumoniae, both 
with a wild type susceptibility pattern (susceptible to 
all antibiotics tested) and Candida glabrata (Figure 1). 
The total number of inpatient urine specimens 
processed during the study week was 279. The 
proportion of urine specimens with isolated pathogens 
was 39.78%. The prevalence of MRSA was 0.35%, ESBL 
E. coli 1.43%, ESBL K. pneumonie 1.79% and multidrug-
resistant Acinetobacter spp. 0.38%. The frequency of 
multidrug-resistant strains within isolated Gram-
positive and Gram-negative species was diverse. One 
third (33.3%) of overall isolated Staphylococcus aureus 
were methicilin-resistant (MRSA), 5.79% of E. coli 
isolates and 26.3% K. pneumoniae were ESBL producers. 
No vancomycin-resistant Enterococcus spp. and 
carbapenem-resistant Enterobacteriaceae spp. were 
isolated (Figure 1). On the day of the surgical antibiotic 
prophylaxis survey 31 patients were registered. 
Seventeen patients (54.83%) had breast surgery, four 
(12.9%) had thyroid surgery, four (12.9%) had vaginal 
hysterectomy, two (6.45%) had neck surgery and one 
(3.22%) had colon surgery, bile duct surgery, abdominal 
hysterectomy and ovarian surgery. Type 1 were 67.74% 
operative procedures, Type 2 were 32.25% operative 
procedures. The patients who had Type 1 procedure 
and administred prophylaxis had breast surgery. The 
proportion of patients who had Type 2 procedure and 
received prophylaxis according to the Croatian National 
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Guidelines (single pre-operative dose of 1 g cefazoline, 
600 mg clindamycin and 1 g cefazoline plus 500 mg 
metronidazole depending of the operative procedure) 
was 80%. Other patients received prolonged antibiotic 
therapy during the day of the operative procedure 
following departmental guidelines for patients with 
specific risk factors (Table 1). Overall proportion of 
patients who continued surgical prophylaxis, 
overstepping guidelines, was 6.4%.
Discussion
Our study shows that multidrug-resistant micro-
organisms’ prevalence in our institution is comparable 
to other prevalence studies on MDR micrororganisms. 
In 2012 a large nationwide study in German hospitals 
showed MRSA was the most frequently reported 
causative pathogen in all healthcare-associated 
infections with prevalence 1.53%, ESBL E. coli 0.97%, 
ESBL K. pneumoniae 0.27%, VRE 0.27% and Acinetobacter 
spp. 0.1% [11]. 
As opposed to reports, significant and encouraging is 
the fact that no carbapenem-resistant Enterobacte-
riaceae and vancomycin-resistant Enterococcus spp. 
were isolated (Figure 1). So far carbapenem-resistant 
Enterobacte riaceae species have presented a new 
global threat to carbapenems, our last-line broad 
spectrum antimicrobial agents and are in the spotlight 
of all hospital infection preventionists in Croatia, since 
there have been reports of their 
epidemic spread in the region [12]. 
The proportion of resistant strains 
within isolated species in our 
institution corresponds to antibiotic 
resistance in Croatia and to European 
Centre for Disease Prevention and 
Control (ECDC) Earss-Net latest 
reports, with the exception of high 
MRSA proportion in overall S. aureus 
isolates (33.3%), since the Croatian 
average is 13%. The proportion of 
ESBL producing K. pneumoniae 
strains is lower than the Croatian 
average (36%) [13]. Although point 
prevalence studies have limitations, 
they are a valuable tool for 
assessment of routine data, they can 
help raise and maintain awareness of 
MDR microorganisms and can 
therefore contribute to planning prevention strategies. 
The other part of our study concerning surgical 
antibiotic prophylaxis showed high compliance with 
the Croatian National Guidelines. Published data on 
this subject are in range from appropriate prophylaxis 
in 18.1% cases as in the Italian study, 28% in the Dutch 
study to 93% in the Canadian research [14–16]. The 
interpretation of different compliance rates requires 
caution. It depends on patient cohorts, studies design 
and evaluation methods. The prevalence of surgical 
antibiotic prophylaxis prolongation in our institution is 
low and with short duration (no longer than 24 hours). 
The Croatian National Guidelines recommend 
prophylaxis administration for Type 2 operative 
procedures. Type 1 are considered clean procedures 
with low prevalence of surgical site infections and 
antibiotic prophylaxis is recommended only in 
cardiovascular surgery and prosthetic implants 
insertion. No recommendations are given on breast 
surgery prophylaxis. It is considered clean surgery and 
the effectiveness of prophylaxis is not clear. In our 
institution, the decision on prophylaxis is based on the 
patient’s general state and local risk factors for surgical 
site infection development. Further research of this 
issue is needed, since recommendations and guidelines 
are not consistent.
Our study shows that point prevalence studies are an 
inexpensive and fast way to provide significant data 
and to unfold new research ground for clinicians and 
hospital infection practitioners in their efforts for better 
patient care and prevention of healthcare-associated 
infections management, using costless tools such as 
hand hygiene and rational antibiotic prescribing.
Figure 1. Gram-positive and Gram-negative bacteria isolated in 
blood and urine specimens and the prevalence of antimicrobial 
drugs’ sensitive and  multidrug-resistant strains.
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1 g + 500 mg
Wound Type 1. 21 (67.74%) 4  (19.04%) 3 1 0 0 (0%)
Wound Type 2. 10 (32.26%) 8  (80%) 4 1 3 2  (20%) Departmental guidelines
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